Does tumor heterogeneity limit the use of the Weiss criteria in the evaluation of adrenocortical tumors?
Adrenal incidentalomas are detected more frequently with high-resolution imaging modalities. It is difficult to distinguish between benign and malignant lesions despite the so-called histologic Weiss criteria, imaging features, and molecular studies. We here present a 52 yr-old man who was found to have an adrenal incidentaloma during an annual check-up at his urologist. An 8 cm large adrenal lesion was detected on ultrasound, computed tomography, and magnetic resonance imaging with imaging features suggestive of malignancy. The lesion was hormonally inactive. A left-sided adrenalectomy was performed and histologic grading revealed a Weiss score of 2, suggesting a benign tumor. However, on further follow-up, the patient developed a local recurrence and pulmonary metastases diagnosed 6 yr after initial presentation. After repeat surgery in the left adrenal bed adrenocortical tumor tissue had a Weiss score of 8, clearly suggesting histologic malignancy. The patient received adjuvant mitotane therapy. Under this therapy, he developed a right-sided adrenal mass (contralateral from the primary tumor) of 2 cm size which disappeared during the following 9 months, whereas the pulmonary metastases remained unchanged, suggesting tumor clones with a variable response to treatment or spontaneous apoptosis. This case suggests that adrenal incidentalomas larger than 6 cm with imaging features such as intratumoral necrosis suggestive of malignancy, should be managed as potential cancers independent of the so-called Weiss criteria. In such patients, close follow-up examinations including high-resolution imaging (preferably 3 monthly) are needed and should be carried out by a physician familiar/specialized in endocrine oncology.
Pohlink
C
C
Department of Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany.
Tannapfe
A
A
Eichfeld
U
U
Schmidt
F
F
Führer
D
D
Paschke
R
R
Koch
C A
CA
D000302:Adrenal Cortex / Q000473:pathology; D000306:Adrenal Cortex Neoplasms / Q000175:diagnosis* / Q000473:pathology*; D018246:Adrenocortical Adenoma / Q000175:diagnosis* / Q000473:pathology*; D003937:Diagnosis, Differential; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging / Q000379:methods*
Acta Med Scand. 1968 Sep;184(3):211-4
5703975
Radiology. 1996 Sep;200(3):737-42
8756924
AJR Am J Roentgenol. 1994 Dec;163(6):1413-8
7992738
Eur J Nucl Med. 1995 Apr;22(4):315-21
7607261
J Comput Assist Tomogr. 1986 Mar-Apr;10 (2):242-53
3950151
Cancer. 2002 May 1;94(9):2333-43
12015757
Radiol Clin North Am. 1984 Dec;22(4):891-5
6515022
World J Surg. 2001 Jul;25(7):914-26
11572033
AJR Am J Roentgenol. 1985 Jan;144(1):61-5
3871149
Surgery. 2000 Dec;128(6):973-82;discussion 982-3
11114632
Clin Radiol. 1994 Nov;49(11):796-9
7955847
AJR Am J Roentgenol. 1986 Sep;147(3):493-6
3488652
J Cancer Res Clin Oncol. 2001;127(3):143-55
11260859
Cancer Res. 2001 Sep 15;61(18):6762-7
11559548
World J Surg. 1993 Sep-Oct;17(5):634-9
8273385
Arch Intern Med (Chic). 1945 Nov-Dec;76:284-91
21011882
J Clin Endocrinol Metab. 2000 Feb;85(2):637-44
10690869
Endocr Rev. 1995 Aug;16(4):460-84
8521790
Rev Hosp Clin Fac Med Sao Paulo. 2002 Nov-Dec;57(6):251-6
12612756
J Nucl Med. 1994 Jul;35(7):1145-52
8014672
Cancer. 1993 Dec 1;72(11):3145-55
8242539
Urology. 2001 Jan;57(1):176-82
11164177
Acta Radiol. 1988 Sep-Oct;29(5):519-22
3166873
J Clin Endocrinol Metab. 2002 Dec;87(12):5367-84
12466322
Urology. 1975 May;5(5):691-5
1129901
Radiology. 1988 Jan;166(1 Pt 1):121-3
3336671
J Comput Assist Tomogr. 1994 May-Jun;18(3):432-8
8188912
J Clin Oncol. 2002 Feb 15;20(4):941-50
11844815
Radiology. 1991 May;179(2):415-8
2014283
Arch Surg. 1997 Aug;132(8):914-9
9267279
Br J Surg. 1991 Jul;78(7):828-33
1873713
Am J Surg Pathol. 1984 Mar;8(3):163-9
6703192